Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Nov 04  •  04:00PM ET
78.08
Dollar change
-0.36
Percentage change
-0.46
%
IndexS&P 500 P/E204.02 EPS (ttm)0.38 Insider Own0.12% Shs Outstand1.27B Perf Week-5.01%
Market Cap99.12B Forward P/E10.90 EPS next Y7.17 Insider Trans-71.14% Shs Float1.27B Perf Month1.61%
Enterprise Value169.76B PEG14.02 EPS next Q0.96 Inst Own87.33% Short Float1.54% Perf Quarter22.92%
Income469.00M P/S0.25 EPS this Y21.11% Inst Trans0.76% Short Ratio2.67 Perf Half Y17.89%
Sales393.94B P/B1.36 EPS next Y9.17% ROA0.18% Short Interest19.52M Perf YTD73.94%
Book/sh57.42 P/C8.78 EPS next 5Y14.55% ROE0.63% 52W High85.15 -8.30% Perf Year38.29%
Cash/sh8.89 P/FCF15.75 EPS past 3/5Y-14.99% -6.37% ROIC0.32% 52W Low43.56 79.25% Perf 3Y-17.10%
Dividend Est.2.66 (3.41%) EV/EBITDA9.89 Sales past 3/5Y8.48% 7.75% Gross Margin13.85% Volatility3.44% 2.31% Perf 5Y38.02%
Dividend TTM2.66 (3.41%) EV/Sales0.43 EPS Y/Y TTM-90.11% Oper. Margin3.19% ATR (14)2.04 Perf 10Y-25.84%
Dividend Ex-DateOct 23, 2025 Quick Ratio0.63 Sales Y/Y TTM6.71% Profit Margin0.12% RSI (14)47.12 Recom1.50
Dividend Gr. 3/5Y9.07% 5.87% Current Ratio0.83 EPS Q/Q-4633.14% SMA20-2.48% Beta0.48 Target Price91.29
Payout72.76% Debt/Eq1.12 Sales Q/Q7.83% SMA501.77% Rel Volume0.96 Prev Close78.44
Employees300000 LT Debt/Eq1.02 EarningsOct 29 BMO SMA20015.73% Avg Volume7.32M Price78.08
IPOOct 01, 1952 Option/ShortYes / Yes EPS/Sales Surpr.17.21% 4.11% Trades Volume7,049,737 Change-0.46%
Date Action Analyst Rating Change Price Target Change
Oct-14-25Initiated Goldman Buy $91
Aug-18-25Upgrade UBS Neutral → Buy $79
Aug-14-25Upgrade Robert W. Baird Neutral → Outperform $82
Feb-13-25Upgrade Leerink Partners Market Perform → Outperform $55 → $75
Feb-12-25Upgrade Cantor Fitzgerald Neutral → Overweight
Jan-30-25Upgrade Edward Jones Hold → Buy
Dec-03-24Upgrade Deutsche Bank Hold → Buy $66
Nov-18-24Upgrade Wells Fargo Equal Weight → Overweight $60 → $66
Oct-10-24Upgrade Barclays Equal Weight → Overweight $63 → $82
Oct-04-24Upgrade TD Cowen Hold → Buy $59 → $85
Today 11:22AM
09:45AM
06:57AM
05:17AM
Oct-31-25 03:10PM
05:51PM Loading…
Oct-30-25 05:51PM
04:45PM
04:06PM
03:51PM
03:35PM
01:25PM
10:52AM
07:11AM
01:33AM
Oct-29-25 10:03PM
04:15PM Loading…
04:15PM
04:14PM
12:00PM
11:18AM
11:04AM
10:50AM
10:04AM
09:31AM
09:31AM
09:30AM
09:00AM
08:12AM
08:03AM
07:51AM
07:40AM
07:13AM Loading…
07:13AM
07:07AM
06:50AM
06:42AM
06:30AM
05:47AM
05:27AM
04:38AM
03:40AM
Oct-28-25 04:20PM
08:33AM
Oct-27-25 11:10PM
12:04PM
08:43AM
Oct-26-25 05:05AM
Oct-25-25 12:17PM
08:33AM
Oct-24-25 09:15AM
Oct-23-25 05:45PM
09:40AM
06:27AM
Oct-22-25 10:00AM
09:00AM
04:15AM
Oct-21-25 11:40AM
10:33AM
09:15AM
Oct-20-25 06:19AM
Oct-19-25 10:16AM
Oct-17-25 05:45PM
03:14PM
10:18AM
08:37AM
Oct-16-25 09:40PM
07:07PM
05:09PM
01:16PM
01:10PM
10:19AM
09:50AM
09:40AM
08:50AM
03:15AM
03:01AM
02:02AM
Oct-15-25 07:48PM
03:16PM
01:52PM
12:10PM
11:36AM
10:54AM
10:00AM
09:41AM
09:15AM
08:31AM
08:00AM
07:10AM
Oct-14-25 09:44AM
08:58AM
08:00AM
Oct-13-25 08:44AM
08:39AM
Oct-11-25 01:33PM
10:00AM
Oct-10-25 05:45PM
Oct-09-25 05:51PM
05:24PM
09:49AM
09:30AM
09:00AM
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Finucane Anne A.DirectorAug 20 '25Sale71.027,500532,65022,156Aug 29 04:29 PM
Finucane Anne A.DirectorAug 20 '25Proposed Sale70.977,500532,275Aug 19 06:57 PM
SANSONE GUY PDirectorJun 05 '25Buy63.701,570100,00912,007Jun 09 08:22 AM
ROBBINS LARRYDirectorMay 02 '25Sale67.862,276,068154,444,7589,670,731May 06 04:15 PM
ROBBINS LARRYDirectorMay 05 '25Sale67.411,323,93289,249,9458,346,799May 06 04:15 PM
ROBBINS LARRYDirectorMay 06 '25Sale66.67150,00010,000,7108,196,799May 06 04:15 PM
Shah Prem SEVP and Group PresidentMar 17 '25Option Exercise62.2184652,63043,190Mar 18 04:51 PM
Clark James DavidSVP, Cont & Chief Acct OfficerMar 05 '25Option Exercise62.217,513467,38415,907Mar 07 04:56 PM
Clark James DavidSVP, Cont & Chief Acct OfficerMar 05 '25Sale66.357,513498,4888,394Mar 07 04:56 PM
Clark James DavidOfficerMar 05 '25Proposed Sale66.357,513498,489Mar 05 05:25 PM
Mahoney Michael FDirectorFeb 18 '25Buy66.7030,0002,001,00039,356Feb 19 12:35 PM